HIV vaccine knowledge and beliefs among communities at elevated risk: conspiracies, questions and confusion
- PMID: 16396058
- PMCID: PMC2640722
HIV vaccine knowledge and beliefs among communities at elevated risk: conspiracies, questions and confusion
Abstract
HIV vaccines offer the best long-term hope of controlling the AIDS pandemic. We explored HIV vaccine knowledge and beliefs among communities at elevated risk for HIV/AIDS. Participants (N=99; median age=33 years; 48% female; 22% African-American; 44% Latino; 28% white; 6% other) were recruited from seven high-risk venues in Los Angeles, California, using purposive, venue-based sampling. Results from nine focus groups revealed: 1) mixed beliefs and conspiracy theories about the existence of HIV vaccines; 2) hopefulness and doubts about future HIV vaccine availability; 3) lack of information about HIV vaccines; and 4) confusion about vaccines and how they work. Tailored HIV vaccine education that addresses the current status of HIV vaccine development and key vaccine concepts is warranted among communities at risk. Ongoing dialogue among researchers, public health practitioners and communities at risk may provide a vital opportunity to dispel misinformation and rumors and to cultivate trust, which may facilitate HIV vaccine trial participation and uptake of future HIV vaccines.
Similar articles
-
Willingness to participate in HIV vaccine trials: the impact of trial attributes.Prev Med. 2007 Jun;44(6):554-7. doi: 10.1016/j.ypmed.2006.12.007. Epub 2006 Dec 24. Prev Med. 2007. PMID: 17275895 Free PMC article.
-
African-American and Hispanic perceptions of HIV vaccine clinical research: a qualitative study.Am J Health Promot. 2014 Nov-Dec;29(2):e82-90. doi: 10.4278/ajhp.130125-QUAL-48. Epub 2014 Jan 16. Am J Health Promot. 2014. PMID: 24432823
-
HIV vaccine trial participation among ethnic minority communities: barriers, motivators, and implications for recruitment.J Acquir Immune Defic Syndr. 2006 Feb 1;41(2):210-7. doi: 10.1097/01.qai.0000179454.93443.60. J Acquir Immune Defic Syndr. 2006. PMID: 16394854
-
Posttrial HIV vaccine adoption: concerns, motivators, and intentions among persons at risk for HIV.J Acquir Immune Defic Syndr. 2004 Nov 1;37(3):1393-403. doi: 10.1097/01.qai.0000127064.84325.ad. J Acquir Immune Defic Syndr. 2004. PMID: 15483469
-
Racial/ethnic differences in trust in health care: HIV conspiracy beliefs and vaccine research participation.J Gen Intern Med. 2014 Jan;29(1):140-6. doi: 10.1007/s11606-013-2554-6. J Gen Intern Med. 2014. PMID: 23979684 Free PMC article.
Cited by
-
Perception of potential harm and benefits of HIV vaccine trial participation: A qualitative study from urban Tanzania.PLoS One. 2019 Nov 8;14(11):e0224831. doi: 10.1371/journal.pone.0224831. eCollection 2019. PLoS One. 2019. PMID: 31703092 Free PMC article. Clinical Trial.
-
Conceptual framework for behavioral and social science in HIV vaccine clinical research.Vaccine. 2011 Oct 13;29(44):7794-800. doi: 10.1016/j.vaccine.2011.07.108. Epub 2011 Aug 5. Vaccine. 2011. PMID: 21821083 Free PMC article.
-
HIV-related 'conspiracy beliefs': lived experiences of racism and socio-economic exclusion among people living with HIV in New York City.Cult Health Sex. 2019 Apr;21(4):373-386. doi: 10.1080/13691058.2018.1470674. Epub 2018 Jun 8. Cult Health Sex. 2019. PMID: 29883299 Free PMC article.
-
Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study.PLoS One. 2018 Feb 8;13(2):e0191251. doi: 10.1371/journal.pone.0191251. eCollection 2018. PLoS One. 2018. PMID: 29420549 Free PMC article.
-
Decisions to participate in research: views of underserved minority drug users with or at risk for HIV.AIDS Care. 2008 Nov;20(10):1224-32. doi: 10.1080/09540120701866992. AIDS Care. 2008. PMID: 18608070 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical